Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
HPB & Spleen3 May 2024

Challenges and Approaches in Treating Intraductal Papillary Neoplasms

Researchers discuss current strategies and challenges in diagnosing and treating intraductal papillary neoplasms (IPNs) of the bile duct and pancreatic duct, which are precursors to pancreatic cancer and cholangiocarcinoma. Modern imaging, biomarkers, and molecular tests are aiding in diagnosis, but treatment should be individualized based…

HPB & Spleen3 May 2024

Optimizing Prediction Models for Pancreatic Fistula after Pancreatectomy

Postoperative pancreatic fistula (POPF) is a common complication following pancreatectomy, with over sixty prediction models existing primarily for pancreaticoduodenectomy. However, these models have shown suboptimal accuracy across diverse populations. Future research should focus on developing and validating prediction models for distal and central pancreatectomy, incorporating…

Br J Surg2 May 2024

Impact of Adjuvant Chemotherapy on Recurrence and Survival for Adenocarcinoma from Intraductal Papillary Mucinous Neoplasia

Adjuvant chemotherapy following resection for adenocarcinoma from intraductal papillary mucinous neoplasia did not show reduced recurrence rates or improved survival outcomes in a multicenter study. Various chemotherapy regimens were not associated with superior outcomes in any high-risk subgroup, indicating that chemotherapy may not influence recurrence…

HPB & Spleen2 May 2024

Total Neoadjuvant Therapy in Pancreatic Cancer: Undefined and Inconsistent

Researchers examined the concept of total neoadjuvant therapy (TNT) for pancreatic ductal adenocarcinoma (PDAC), finding that the term "total" is not consistently defined. Although it has gained popularity for its promise of comprehensive preoperative treatment, the current understanding and protocols vary widely, with inconsistent therapy…

HPB & Spleen2 May 2024

Feasibility and Safety of Highly Complex Liver Resections

Highly complex liver resections (HCLR) can be performed with an acceptable complication profile, similar to major non-HCLR procedures. However, HCLR is associated with increased rates of biliary complications, readmissions, and reoperations. No postoperative 90-day mortality was observed in the HCLR group. Tertiary hepato-pancreato-biliary centers should…

Am Surg2 May 2024

Management of Infected Collections in Acute Pancreatitis: To Drain or Not Drain?

Recent literature advocates for delaying catheter drainage in acute pancreatitis, but critically ill patients with severe disease and infected peri-pancreatic collections may still benefit from drainage procedures. A retrospective review of 72 patients showed high rates of ICU admission, respiratory and renal failure, and in-hospital…

Br J Surg1 May 2024

Laparoscopic Liver Resection VS Radiofrequency Ablation for Small Hepatocellular Carcinoma

Patients with small hepatocellular carcinoma showed similar overall and recurrence-free survival rates whether treated with laparoscopic liver resection or radiofrequency ablation. This randomized clinical trial suggests that percutaneous radiofrequency ablation may offer comparable therapeutic effects to laparoscopic liver resection for this patient population.